FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972506035> ?p ?o ?g. }

• W1972506035 endingPage "298" @default.
• W1972506035 startingPage "288" @default.
• W1972506035 abstract "Fabry disease is an X-linked genetic disorder characterized by deficient activity of α-galactosidase A (GLA) and accumulation of glycolipids, and various GLA gene mutations lead to a wide range of clinical phenotypes from the classic form to the later-onset one. To investigate the biochemical heterogeneity and elucidate the basis of the disease using available clinical samples, we measured GLA activity, GLA protein and accumulated globotriaosylsphingosine (Lyso-Gb3), a biomarker of this disease, in plasma samples from Fabry patients. The analysis revealed that both the enzyme activity and the protein level were apparently decreased, and the enzyme activity was well correlated with the protein level in many Fabry patients. In these cases, a defect of biosynthesis or excessive degradation of mutant GLAs should be involved in the pathogenesis, and the residual protein level would determine the accumulation of Lyso-Gb3 and the severity of the disease. However, there are some exceptional cases, i.e., ones harboring p.C142Y, p.R112H and p.M296I, who exhibit a considerable amount of GLA protein. Especially, a subset of Fabry patients with p.R112H or p.M296I has been attracted interest because the patients exhibit almost normal plasma Lyso-Gb3 concentration. Structural analysis revealed that C142Y causes a structural change at the entrance of the active site. It will lead to a complete enzyme activity deficiency, resulting in a high level of plasma Lyso-Gb3 and the classic Fabry disease. On the other hand, it is thought that R112H causes a relatively large structural change on the molecular surface, and M296I a small one in a restricted region from the core to the surface, both the structural changes being far from the active site. These changes will cause not only partial degradation but also degeneration of the mutant GLA proteins, and the degenerated enzymes exhibiting small and residual activity remain and probably facilitate degradation of Lyso-Gb3 in plasma, leading to the later-onset phenotype. The results of this comprehensive analysis will be useful for elucidation of the basis of Fabry disease." @default.
• W1972506035 created "2016-06-24" @default.
• W1972506035 creator A5004257767 @default.
• W1972506035 creator A5021402208 @default.
• W1972506035 creator A5028778330 @default.
• W1972506035 creator A5033749506 @default.
• W1972506035 creator A5063863185 @default.
• W1972506035 creator A5080278998 @default.
• W1972506035 creator A5085244403 @default.
• W1972506035 creator A5089304014 @default.
• W1972506035 date "2014-01-01" @default.
• W1972506035 modified "2023-10-16" @default.
• W1972506035 title "Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease" @default.
• W1972506035 cites W1483366709 @default.
• W1972506035 cites W1493695909 @default.
• W1972506035 cites W1583538379 @default.
• W1972506035 cites W1595555227 @default.
• W1972506035 cites W1964043362 @default.
• W1972506035 cites W1972467257 @default.
• W1972506035 cites W1978029388 @default.
• W1972506035 cites W1986966812 @default.
• W1972506035 cites W2012854657 @default.
• W1972506035 cites W2020755394 @default.
• W1972506035 cites W2020999344 @default.
• W1972506035 cites W20264579 @default.
• W1972506035 cites W2030162832 @default.
• W1972506035 cites W2040332507 @default.
• W1972506035 cites W2040951253 @default.
• W1972506035 cites W2040965053 @default.
• W1972506035 cites W2041464194 @default.
• W1972506035 cites W2044017619 @default.
• W1972506035 cites W2045561472 @default.
• W1972506035 cites W2046037112 @default.
• W1972506035 cites W2051628563 @default.
• W1972506035 cites W2053220248 @default.
• W1972506035 cites W2067328535 @default.
• W1972506035 cites W2071486919 @default.
• W1972506035 cites W2075481548 @default.
• W1972506035 cites W2077501220 @default.
• W1972506035 cites W2081735281 @default.
• W1972506035 cites W2094976188 @default.
• W1972506035 cites W2097776291 @default.
• W1972506035 cites W2099728000 @default.
• W1972506035 cites W2101425200 @default.
• W1972506035 cites W2104940206 @default.
• W1972506035 cites W2113070561 @default.
• W1972506035 cites W2113915213 @default.
• W1972506035 cites W2116253057 @default.
• W1972506035 cites W2134729831 @default.
• W1972506035 cites W2136457004 @default.
• W1972506035 cites W2137098232 @default.
• W1972506035 cites W2140319432 @default.
• W1972506035 cites W2165232003 @default.
• W1972506035 cites W2169128371 @default.
• W1972506035 cites W2324125117 @default.
• W1972506035 cites W2332862830 @default.
• W1972506035 cites W2404114950 @default.
• W1972506035 cites W4385997603 @default.
• W1972506035 doi "https://doi.org/10.1016/j.ymgmr.2014.07.005" @default.
• W1972506035 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5121323" @default.
• W1972506035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27896103" @default.
• W1972506035 hasPublicationYear "2014" @default.
• W1972506035 type Work @default.
• W1972506035 sameAs 1972506035 @default.
• W1972506035 citedByCount "10" @default.
• W1972506035 countsByYear W19725060352015 @default.
• W1972506035 countsByYear W19725060352018 @default.
• W1972506035 countsByYear W19725060352019 @default.
• W1972506035 countsByYear W19725060352020 @default.
• W1972506035 countsByYear W19725060352022 @default.
• W1972506035 countsByYear W19725060352023 @default.
• W1972506035 crossrefType "journal-article" @default.
• W1972506035 hasAuthorship W1972506035A5004257767 @default.
• W1972506035 hasAuthorship W1972506035A5021402208 @default.
• W1972506035 hasAuthorship W1972506035A5028778330 @default.
• W1972506035 hasAuthorship W1972506035A5033749506 @default.
• W1972506035 hasAuthorship W1972506035A5063863185 @default.
• W1972506035 hasAuthorship W1972506035A5080278998 @default.
• W1972506035 hasAuthorship W1972506035A5085244403 @default.
• W1972506035 hasAuthorship W1972506035A5089304014 @default.
• W1972506035 hasBestOaLocation W19725060351 @default.
• W1972506035 hasConcept C104317684 @default.
• W1972506035 hasConcept C126322002 @default.
• W1972506035 hasConcept C127716648 @default.
• W1972506035 hasConcept C134018914 @default.
• W1972506035 hasConcept C143065580 @default.
• W1972506035 hasConcept C153911025 @default.
• W1972506035 hasConcept C181199279 @default.
• W1972506035 hasConcept C185592680 @default.
• W1972506035 hasConcept C2776788019 @default.
• W1972506035 hasConcept C2777404818 @default.
• W1972506035 hasConcept C2779134260 @default.
• W1972506035 hasConcept C2779969927 @default.
• W1972506035 hasConcept C2780942790 @default.
• W1972506035 hasConcept C2781197716 @default.
• W1972506035 hasConcept C28212737 @default.
• W1972506035 hasConcept C2994225774 @default.
• W1972506035 hasConcept C501734568 @default.

• next